Literature DB >> 21317176

A randomised trial of sheathed versus standard forceps for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileum.

Maneesh Dave1, Laura A Johnson, Seth T Walk, Vincent B Young, Ryan W Stidham, Meghana N Chaudhary, Jessica Funnell, Peter D R Higgins.   

Abstract

BACKGROUND: The study of intestinal microbiota has been revolutionised by the use of molecular methods, including terminal restriction fragment length polymorphism (T-RFLP) analysis. Microbiota studies of Crohn's disease patients have examined samples from stool or from the neoterminal ileum with a standard biopsy forceps, which could be contaminated by colonic bacteria when the forceps passes through the colonoscope channel.
OBJECTIVE: To determine whether sheathed biopsy forceps are able to obtain terminal ileal microbiota samples with less colonic bacterial contamination compared with unsheathed (standard) biopsy forceps.
DESIGN: Prospective randomised single-centre study. PATIENTS AND METHODS: Four (paired) biopsy specimens were obtained from adjacent locations in the terminal ileum using the sheathed and standard forceps of 27 consecutive subjects undergoing colonoscopy and the microbiota were characterised using T-RFLP. The Bray-Curtis similarity index between samples (sheathed vs unsheathed forceps) was calculated within patients and significant differences were tested for across all patients.
RESULTS: There was not a significant difference in the microbial diversity of samples obtained using sheathed versus unsheathed forceps. The difference in microbial diversity between patients was much greater than the variability within patients by proximal versus distal site or by forceps type. LIMITATIONS: T-RFLP is based on PCR amplification, so it is not always sensitive to rare bacterial species.
CONCLUSION: Standard unsheathed forceps appear to be sufficient for microbiota sample collection from the terminal ileum.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317176      PMCID: PMC4244887          DOI: 10.1136/gut.2010.224337

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  Terminal restriction fragment length polymorphism data analysis for quantitative comparison of microbial communities.

Authors:  Christopher B Blackwood; Terry Marsh; Sang-Hoon Kim; Eldor A Paul
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

2.  Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods.

Authors:  Hidenori Hayashi; Mitsuo Sakamoto; Yoshimi Benno
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

3.  Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota.

Authors:  Vincent B Young; Thomas M Schmidt
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 4.  Phylogenetic identification of uncultured pathogens using ribosomal RNA sequences.

Authors:  T M Schmidt; D A Relman
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

5.  Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.

Authors:  A Suau; R Bonnet; M Sutren; J J Godon; G R Gibson; M D Collins; J Doré
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

6.  Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.

Authors:  P Rutgeerts; M Hiele; K Geboes; M Peeters; F Penninckx; R Aerts; R Kerremans
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

7.  Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA.

Authors:  W T Liu; T L Marsh; H Cheng; L J Forney
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

8.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

9.  Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul Rutgeerts; Gert Van Assche; Séverine Vermeire; Geert D'Haens; Filip Baert; Maja Noman; Isolde Aerden; Gert De Hertogh; Karel Geboes; Martin Hiele; Andre D'Hoore; Freddy Penninckx
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

10.  Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas.

Authors:  Xiang Jun Shen; John F Rawls; Thomas Randall; Lauren Burcal; Caroline N Mpande; Natascha Jenkins; Biljana Jovov; Zaid Abdo; Robert S Sandler; Temitope O Keku
Journal:  Gut Microbes       Date:  2010-05-13
View more
  9 in total

Review 1.  Recent Advancements in Intestinal Microbiota Analyses: A Review for Non-Microbiologists.

Authors:  Xiao-Wei Feng; Wen-Ping Ding; Ling-Yun Xiong; Liang Guo; Jia-Ming Sun; Peng Xiao
Journal:  Curr Med Sci       Date:  2018-12-07

2.  Total parenteral nutrition-associated lamina propria inflammation in mice is mediated by a MyD88-dependent mechanism.

Authors:  Eiichi A Miyasaka; Yongjia Feng; Valeriy Poroyko; Nicole R Falkowski; John Erb-Downward; Merritt G Gillilland; Katie L Mason; Gary B Huffnagle; Daniel H Teitelbaum
Journal:  J Immunol       Date:  2013-05-10       Impact factor: 5.422

3.  Microbiota of the Oropharynx and Endoscope Compared to the Esophagus.

Authors:  Ikenna C Okereke; Aaron L Miller; Catherine F Hamilton; Adam L Booth; Gabriel L Reep; Clark L Andersen; Sandy T Reynolds; Richard B Pyles
Journal:  Sci Rep       Date:  2019-07-15       Impact factor: 4.379

4.  Spatial distribution of live gut microbiota and bile acid metabolism in various parts of human large intestine.

Authors:  Daisuke Chinda; Toshihiko Takada; Tatsuya Mikami; Kensuke Shimizu; Kosuke Oana; Tetsu Arai; Kazuki Akitaya; Hirotake Sakuraba; Miyuki Katto; Yusuke Nagara; Hiroshi Makino; Daichi Fujii; Kenji Oishi; Shinsaku Fukuda
Journal:  Sci Rep       Date:  2022-03-04       Impact factor: 4.379

5.  Depth-dependent differences in community structure of the human colonic microbiota in health.

Authors:  Aonghus Lavelle; Grainne Lennon; Neil Docherty; Aine Balfe; Hugh E Mulcahy; Glen Doherty; Diarmuid O Donoghue; John M Hyland; Fergus Shanahan; Kieran Sheahan; J Calvin Coffey; Desmond C Winter; P Ronan O Connell
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

6.  Association of gut microbiota with post-operative clinical course in Crohn's disease.

Authors:  Neelendu Dey; David A W Soergel; Susanna Repo; Steven E Brenner
Journal:  BMC Gastroenterol       Date:  2013-08-22       Impact factor: 3.067

7.  Species Level Description of the Human Ileal Bacterial Microbiota.

Authors:  Heidi Cecilie Villmones; Erik Skaaheim Haug; Elling Ulvestad; Nils Grude; Tore Stenstad; Adrian Halland; Øyvind Kommedal
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

Review 8.  Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research.

Authors:  Shaocun Zhang; Xiaocang Cao; He Huang
Journal:  Front Cell Infect Microbiol       Date:  2017-02-24       Impact factor: 5.293

9.  Effects of synbiotics on ileal microbiota.

Authors:  Shunichiro Komatsu; Eiji Sakamoto; Takashi Asahara; Koji Nomoto; Masato Nagino
Journal:  Indian J Med Res       Date:  2018-01       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.